Anaphylaxis Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 233716|Published date: 13 September, 2024
Anal Cancer Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 992848|Published date: 13 September, 2024
Amblyopia Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 868540|Published date: 13 September, 2024
Alcohol Use Disorder Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 349111|Published date: 13 September, 2024
Alagille Syndrome Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 233891|Published date: 13 September, 2024
Aicardi Goutieres Syndrome Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 203276|Published date: 13 September, 2024
Agoraphobia Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 125561|Published date: 13 September, 2024
Acute Pyelonephritis Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 882726|Published date: 12 September, 2024
Adrenocortical Carcinoma Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 400605|Published date: 12 September, 2024
Adrenal Crisis Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 357077|Published date: 12 September, 2024
Adenoid Cystic Carcinoma Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 393885|Published date: 12 September, 2024
Addison’s Disease Market Insight, Epidemiology, and Market Forecast 2024-2032
Therapeutics
$4750|GR - 502598|Published date: 12 September, 2024